Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics

21 Nov 2013

Abstract excerpt

// Ida Grundberg 1,2 , Sara Kiflemariam 1 , Marco Mignardi 1,3 , Juliana Imgenberg-Kreuz 1,4 , Karolina Edlund 1,5 , Patrick Micke 1 , Magnus Sundström 1 , Tobias Sjöblom 1 , Johan Botling 1* and Mats Nilsson 1,3* 1 Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Rudbeck Laboratory. 2 Present address: Olink Bioscience, Uppsala Science Park, Uppsala, Sweden. 3 Science for Life...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to Molecular Biology Techniques and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24280411
DOI: 10.18632/oncotarget.1527

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnosticsPMID 24280411Read ↗

Concurrent in situ analysis of point mutations and immune infiltrate in FFPE cancers.Semantic proximity Read ↗

Robust RNA-based in situ mutation detection delineates colorectal cancer subclonal evolutionSemantic proximity Read ↗

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay.Semantic proximity Read ↗

KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approach.Semantic proximity Read ↗

HistoMosaic Detecting KRAS G12V Mutation Across Colorectal Cancer Tissue Slices through in Situ PCR.Semantic proximity Read ↗

Rapid assessment of 3-dimensional intra-tumor heterogeneity through cycling temperature capillary electrophoresis.Semantic proximity Read ↗

Hybridization-Induced Aggregation Technology for Practical Clinical Testing: KRAS Mutation Detection in Lung and Colorectal Tumors.Semantic proximity Read ↗

Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probesSemantic proximity Read ↗

Laboratory methods for<i>KRAS</i>mutation analysisSemantic proximity Read ↗

Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas.Semantic proximity Read ↗

Targeted DNA sequencing and in situ mutation analysis using mobile phone microscopy.Semantic proximity Read ↗

Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.